Page last updated: 2024-09-04

dc 015 and ketanserin

dc 015 has been researched along with ketanserin in 1 studies

*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]

*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]

Compound Research Comparison

Studies
(dc 015)
Trials
(dc 015)
Recent Studies (post-2010)
(dc 015)
Studies
(ketanserin)
Trials
(ketanserin)
Recent Studies (post-2010) (ketanserin)
7003,094335283

Protein Interaction Comparison

ProteinTaxonomydc 015 (IC50)ketanserin (IC50)
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.0016
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.0021
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.015
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.015
5-hydroxytryptamine receptor 1DHomo sapiens (human)0.265
5-hydroxytryptamine receptor 1BHomo sapiens (human)6.5
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0184
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0027
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0016
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.29
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.015
D(2) dopamine receptorRattus norvegicus (Norway rat)1.8
Synaptic vesicular amine transporterHomo sapiens (human)0.18
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, CH; Chern, JW; Chien, SL; Lai, YJ; Lu, GY; Shiau, CY; Tao, PL; Yen, MH1

Other Studies

1 other study(ies) available for dc 015 and ketanserin

ArticleYear
Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents.
    Journal of medicinal chemistry, 1993, Jul-23, Volume: 36, Issue:15

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Quinazolines; Rats; Rats, Inbred SHR; Structure-Activity Relationship

1993